Malignant Mesothelioma in Australia, 1945–2002

References

• Takahashi K, Huuskonen MS, Tossavainen A, Higashi T, Okubo T, Rantanen J. Ecological relationship between mesothelioma incidence/mortality and asbestos consumption in ten Western countries and Japan. J Occup Health. 1999; 41: 8–11.
   Web of Science ®Google Scholar
• Musk AW, de Klerk NH, Eccles JL, et al. Wittenoom, Western Australia: a modern industrial disaster. Am J Ind Med. 1992; 21: 735–47.
   PubMed Web of Science ®Google Scholar
• Leigh J, Corvalan CF, Grimwood A, Berry G, Ferguson DA, Thompson R. The incidence of malignant mesothelioma in Australia 1982-1988. Am J Ind Med. 1991; 20: 643–55.
   PubMed Web of Science ®Google Scholar
• Leigh J. The Australian Mesothelioma Program 1979-1994. In:Peters GA, Peters BJ (eds). The Current Status of the Asbestos Public Health Problem. Vol 9 Sourcebook on Asbestos Disease). London, U.K.: NH, Butterworth, 1994: 1-74.
   Google Scholar
• Leigh J, Davidson P, Hull B. Malignant mesothelioma in Aus-tralia 1945-1995. Proc Inhaled Particles VIII. Ann Occup Hyg. 1997;41 (suppl 1):161-7.
   Google Scholar
• Leigh J, Davidson P, Hull B. Malignant mesothelioma in Aus-tralia (1945-1997). Excerpta Medica Suppl 53. Adv Prey Occup Resp Dis. 1998;299-302.
   Google Scholar
• Leigh J, Davidson P, Hendrie L, Berry D. Malignant mesothe-lioma in Australia (1945-2000). J Occup Health Safety (ANZ). 2001; 17: 453–70
   Google Scholar
• Leigh J, Davidson P, Hendrie L, Berry D. Malignant mesothe-lioma in Australia, 1945-2000. Am J Ind Med. 2002; 41: 188–201
   PubMed Web of Science ®Google Scholar
• Leigh J, Davidson P, Hendrie L, Berry D. Malignant meSothe-lioma in Australia (1945-2000) Ann Occup Hyg. 2002;46 (suppl 1)160-5.
   Google Scholar
• The Colonial Sugar Refining Company Limited. South Pacific Enterprise. Sydney, Australia: Angus and Robertson, 1956,
   Google Scholar
• Hughes RJ. Asbestos. Australian Mineral Industry Annual Review 1976 (including information to June 1977). Bureau of Mineral Resources Geology and Geophysics. Canberra, Aus-tralia: Australian Government Publishing Service, 1978, p 61-62.
   Google Scholar
• National Occupational Health and Safety Commission. Priority Existing Chemical Report No 9. Chrysotile Asbestos. Canberra, Australia, 1999:
   Google Scholar
• Roberts CG, Whaite HM. A survey of dust exposure and lung disease in, the asbestos cement industry in New South Wales. Studies in Industrial Hygiene No 24. New South Wales, Aus-tralia: NSW Dept. of Health, 1952.
   Google Scholar
• Major G. Asbestos dust exposure. In: Proc 1st Aust Pneumoco-niosis Conference, Sydney, Australia, 1968: 467-74.
   Google Scholar
• McNulty JC. Malignant pleural mesothelioma in an asbestos worker. Med J Aust. 1962; 2: 953–4.
   Web of Science ®Google Scholar
• Riddell RJ. Three cases of mesothelioma. Med J Aust. 1966; 2: 554–9.
   PubMedGoogle Scholar
• Mortimer RH, Campbell CB. Asbestos exposure and pleural mesotheliomas. Med J Aust. 1968; 2: 720–2.
   PubMedGoogle Scholar
• Milne J. Fifteen cases of pleural mesothelioma associated with occupational exposure to asbestos in Victoria. Med J Aust. 1969; 2: 669–73.
   PubMed Web of Science ®Google Scholar
• Ferguson DA, Berry G, Jelihovsky T, et al. The Australian Mesothelioma Surveillance Program 1979-1985. Med J Aust. 1987; 147: 166–72.
   PubMed Web of Science ®Google Scholar
• Rogers AJ. Determination of mineral fiber in human tissue by light microscopy and transmission electron microscopy. Ann Occup Hyg. 1984; 28: 1–12.
   PubMed Web of Science ®Google Scholar
• Leigh J, Rogers AJ, Ferguson DA, Mulder HB, Ackad M, Thomp-son R. Lung asbestos fiber content and mesothelioma cell type, site, and survival. Cancer. 1991; 68: 13541.
   Web of Science ®Google Scholar
• , Rogers AJ, Leigh J, Berry G, Ferguson DA, Mulder HB, Ackad M. Relationship between lung asbestos fiber type and concen-tration and relative risk of mesothelioma-a case-control study. Cancer. 1991; 67: 1912–20.
   Google Scholar
• Rogers A, Leigh J, Berry G, et al. Dose-response relationship between airborne and lung asbestos fiber type, length and con-centration and the relative risk of mesothelioma. Ann Occup Hyg. 1994;38 (suppl 1):631-8.
   Google Scholar
• Driscoll T, Baker G, Daniel S, et al. Clinical features of malig-nant mesothelioma in Australia. Aust NZ J Med. 1993; 23: 19–25.
   PubMedGoogle Scholar
• National Occupational Health and Safety Commission (National Institute of Occupational Health and Safety). Aus-tralian Mesothelioma Register Report. The Incidence of Mesothelioma in Australia 1989, 1990, 1991, 1992, 1993, 1994, 1995, 1996, 1997, 1998, 1999, 2000, 2001, 2002, 2003. (Annual Report Series). Canberra, Commonwealth of Australia.
   Google Scholar
• Musk AW, Dolin PJ, Armstrong BK, Ford JM, de Klerk NH, Hobbs MST. The incidence of malignant mesothelioma in Aus-tralia 1947,-1980. Med J Aust. 1989; 150: 242–6.
   PubMed Web of Science ®Google Scholar
• Peto J, Decarli A, La Vecchia C, et al. The European mesothe-lioma epidemic. Br J Cancer. 1999; 79: 566–672.
   Web of Science ®Google Scholar
• Hillerdal G. Mesothelioma: cases associated with non-occupa-tional and low dose exposures. Occup Environ Med. 1999; 56: 505–13.
   PubMed Web of Science ®Google Scholar
• Kjellstrom T, Smartt P. Increased mesothelioma incidence in New Zealand: the asbestos-cancer epidemic has started. NZ Med J. 2000; 113: 485–90.
   PubMed Web of Science ®Google Scholar
• New South Wales Cancer Council. Cancer in New South Wales. Incidence and Mortality 1997. Sydney, Australia: NSW Cancer Council, 2000.
   Google Scholar
• Musk AW, Dewar J, Shilkin KB, Whitaker D. Miliary spread of malignant mesothelioma without a clinically identifiable pleural tumour. Aust NZ J Med. 1991; 21: 460–2.
   PubMedGoogle Scholar
• Grimwood A. Mesothelioma and asbestos in Australia. MPH treatise, University of Sydney, 1988.
   Google Scholar
• NeugutAl, Ahsan H, Antman KH. Incidence of malignant pleu-ral mesothelioma after thoracic radiotherapy. Cancer. 1997; 80: 948–50.
   PubMed Web of Science ®Google Scholar
• Rödelsperger K, Jöckel K-H, Pohlabein H, Romer W, Woitowitz H-J. Asbestos and man-made vitreous fibers as risk factors for diffuse malignant mesothelioma: results from a German hospi-tal-based case-control study. Am J Ind Med. 2001; 38: 1–14.
   Google Scholar
• Muhle H, Bellmann B, Pott E Comparative investigations of the biodurability of mineral fibers in the rat lung. Environ Health Perspect. 1994;102 (suppl 5):163-8.
   Google Scholar
• Oberdorster G. Macrophage-associated responses to chrysotile. Ann Occup Hyg. 1994; 38: 601–15.
   PubMed Web of Science ®Google Scholar
• Wagner JC, Berry G, Skidmore JW, Timbrell V. The effects of the inhalation of asbestos in rats. Br J Cancer. 1974; 29: 252–69.
   PubMed Web of Science ®Google Scholar
• Finkelstein MM, Dufresne A. Inferences on the kinetics of asbestos deposition and clearance among chrysotile miners and millers. Am J Ind Med. 1999; 35: 401–12.
   PubMed Web of Science ®Google Scholar
• de Klerk NH, Musk AW, Williams V, Filion PR, Whitaker D, Shilkin KB. Comparison of measures of exposure to asbestos in former crocidolite workers from Wittenoom Gorge, Western Australia. Arn J Ind Med. 1996; 30: 579–87.
   PubMed Web of Science ®Google Scholar
• Churg A. Deposition and clearance of chrysotile asbestos. Ann Occup Hyg. 1994; 38: 625-33, 424–5.
   Google Scholar
• Churg A, Wright J, Gilks B Depaoli L. Rapid short-term clear-ance of chrysotile compared with amosite asbestos in the guinea pig. Am Rev Resp Dis. 1989; 139: 885–90.
   Google Scholar
• Berry G. Prediction of mesothelioma, lung cancer, and asbesto-sis in former Wittenoom asbestos workers. Br J Ind Med. 1991; 48: 793–802.
   PubMedGoogle Scholar
• de Klerk NH, Armstrong BK, Musk AW, Hobbs MST. Prediction of future cases of asbestos-related disease among former miners and millers of crocidolite in Western Australia. Med J Aust. 1989; 151: 616–20.
   PubMed Web of Science ®Google Scholar
• World Trade Organization. European Communities—Measures affecting asbestos and asbestos-containing products. Report of the panel. WT/DS135/R 18 September 2000. Geneva, Switzer-land: WTO, 2000.
   Google Scholar
• Barroetavena MC, Teschke K, Bates DV. Unrecognized asbestos-induced disease. Am J Ind Med 1996; 29: 183–5.
   PubMed Web of Science ®Google Scholar
• Burdorf A, Swuste PHJJ, Looman CWN. Estimating the futuredevelopments in mesothelioma mortality due to historical asbestos use and its consequences for public health. In: Peters BA, Peters BJ ( eds). Sourcebook on Asbestos Diseases. Vol 18. Charlottesville, VA: Lexis, 1998: 145-67.
   Google Scholar
• Consensus Report. International expert meeting on new advances in the radiology and screening of asbestos-related dis-eases. Scand J Work Environ Health. 2000; 26: 449–54.
   PubMedGoogle Scholar
• AWARD Workshop Group. The diagnosis and attribution of asbestos-related diseases in an Australian context: report of the Adelaide workshop on asbestos related diseases. Adelaide, Australia, October 6-7, 2000. Int J Occup Environ Health. In press.
   Google Scholar